Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Cytosorbents Corporation (CTSO) had Cash Flow from Financial Activities of $0.00M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$8.86M |
|
$-5.13M |
|
$2.73M |
|
$6.13M |
|
$11.91M |
|
$-3.04M |
|
$-2.08M |
|
$-5.13M |
|
$-5.13M |
|
$-5.13M |
|
$-5.13M |
|
$-5.13M |
|
$-5.13M |
|
$-3.04M |
|
$-2.38M |
|
62.74M |
|
62.74M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$17.76M |
|
$7.51M |
|
$22.80M |
|
$40.56M |
|
$16.30M |
|
$10.31M |
|
$22.07M |
|
$38.37M |
|
$2.19M |
|
$-0.76M |
|
$2.19M |
|
62.73M |
|
| Cash Flow Statement Financials | |
$-1.16M |
|
$-0.05M |
|
|
Cash Flow from Financial Activities |
$0.00M |
$7.77M |
|
$6.33M |
|
$-1.44M |
|
$0.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.09 |
|
-- |
|
-- |
|
0.82 |
|
7.73 |
|
69.16% |
|
-34.34% |
|
-34.34% |
|
-- |
|
-57.86% |
|
-57.86% |
|
$-1.15M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
0.61 |
|
1.24 |
|
72.62 |
|
-233.78% |
|
676.65% |
|
-12.64% |
|
-41.01% |
|
$0.04 |
|
$-0.02 |
|
$-0.02 |
|